CIPO Patents = 5

EPO Patents = 2

Forward Citations = 15

Loading Chart...

13 inventors (with patents filed for the assignee):

Richard Alvarez (5 out of 5 patents)

Rodger P McEver (4 out of 33 patents)

Ziad Kawar (4 out of 4 patents)

4. Scott A Rollins (3 out of 18 patents)

5. Russell P Rother (2 out of 38 patents)

6. Ziad S Kawar (0 patent)

7. Ziad S Kawar (0 patent)

8. Rodger P Mcever (0 patent)

5 patents: Sort by Forward Citations

1. 9556266 - Methods of treating sickle cell disease with anti-P-selectin antibodies (2017-01-31),

2. 9068001 - Anti-P-selectin antibodies (2015-06-30),

3. 8945565 - Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies (2015-02-03),

4. 8377440 - Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases (2013-02-19),

5. 7833530 - Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies (2010-11-16),

Selexys Pharmaceuticals Corporation is a biopharmaceutical company focused on developing innovative therapies for inflammatory and autoimmune diseases. The company's lead product candidate, SelG1, is currently in clinical trials for the treatment of sickle cell disease. With a strong team of researchers and a commitment to improving patient outcomes, Selexys is dedicated to advancing the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#56 in Oklahoma City, OK

#258 in Oklahoma

#50,165 in US

Oklahoma City, OK, United States of America

Selexys Pharmaceuticals Corporation

Forward Citations = 15

13 inventors:

Richard Alvarez (5 out of 5 patents)

Rodger P McEver (4 out of 33 patents)

Ziad Kawar (4 out of 4 patents)

4. Scott A Rollins (3 out of 18 patents)

5. Russell P Rother (2 out of 38 patents)

Please report any incorrect information to support@idiyas.com

5 patents (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com